FAQs
What is the primary focus of the McElwain Ward at The Royal Marsden?
The McElwain Ward focuses on providing high-quality care for children, teenagers, and young people with cancer, including treatments such as chemotherapy, radiotherapy, and stem cell transplantation.
What qualifications are required for the Staff Nurse (Band 6) position?
Candidates must be a registered nurse with relevant experience, particularly in pediatric oncology or similar settings, and demonstrate a commitment to delivering evidence-based nursing care.
Are there opportunities for professional development in this role?
Yes, The Royal Marsden offers unique learning opportunities and career development pathways in specialized cancer practice and care.
What type of shift management experience is expected in this role?
The Staff Nurse is expected to develop an understanding of managing shifts with the guidance of the Ward Sister/Charge Nurse.
Who can I contact for more information about this position?
For further details or informal visits, you can contact Janine Shearing, the Ward Manager, at janine.shearing@rmh.nhs.uk.
What values does The Royal Marsden prioritize in its staff?
The Royal Marsden seeks employees who aspire to excellence, share the organization's values, and play a crucial role in its ongoing achievements.
Is flexible working supported at The Royal Marsden?
Yes, The Royal Marsden welcomes flexible working requests from point of hire to support employees' work-life balance.
Where are the locations of The Royal Marsden hospitals?
The Royal Marsden has two hospitals located in Chelsea, London, and Sutton, Surrey, as well as a Medical Daycare Unit in Kingston Hospital.
What is the main responsibility of the Staff Nurse in McElwain Ward?
The main responsibility of the Staff Nurse is to plan, document, deliver, and evaluate evidence-based nursing care for patients efficiently, working in conjunction with the shift coordinator.
How does The Royal Marsden stand out from other children's cancer centers?
The Royal Marsden is a world leader in offering "First in Child" clinical trials for young cancer patients and collaborates with a specialist multi-professional drug development team.